Compare SLE & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SLE | SCNI |
|---|---|---|
| Founded | 2014 | 2003 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1M | 2.6M |
| IPO Year | 2019 | N/A |
| Metric | SLE | SCNI |
|---|---|---|
| Price | $0.51 | $0.85 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | ★ 262.2K | 34.8K |
| Earning Date | 11-13-2025 | 03-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | ★ $11,568,000.00 | $1,147,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $20.37 | N/A |
| P/E Ratio | ★ N/A | $3.28 |
| Revenue Growth | N/A | ★ 303.87 |
| 52 Week Low | $0.53 | $0.61 |
| 52 Week High | $26.00 | $6.18 |
| Indicator | SLE | SCNI |
|---|---|---|
| Relative Strength Index (RSI) | 34.90 | 48.47 |
| Support Level | $0.62 | $0.78 |
| Resistance Level | $0.76 | $0.96 |
| Average True Range (ATR) | 0.08 | 0.07 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 9.11 | 56.47 |
Super League Enterprise Inc is the rocket ship to the metaverse. It is a creator and publisher of content experiences and media solutions across the globe's immersive platforms. Its solutions provide incomparable access to massive audiences that gather in immersive digital spaces to socialize, play, explore, collaborate, shop, learn, and create. The company offers a complete range of development, distribution, monetization, and optimization capabilities designed to engage users through dynamic, energized programs. It generates revenue from advertising, including immersive game world and experience publishing and in-game media products, direct-to-consumer offers, including in-game items, e-commerce, game passes and ticketing and digital collectibles, and content and technology.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.